# OnCo record arce-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/arce-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "arce-therapeutics" ;
  schema:name "ARCE Therapeutics"@en ;
  schema:alternateName "承寶生技"@en ;
  schema:description "ARCE Therapeutics makes CAR-T cell therapy, in which a patient's own immune cells are re-engineered to attack cancer. Its first product, ARD103, is in an early trial in the United States for acute myeloid leukaemia and myelodysplastic syndrome that has come back or not responded to treatment."@en ;
  schema:url <https://onco.cc/companies/arce-therapeutics/>, <https://www.arcetherapeutics.com/> ;
  schema:dateModified "2026-10-29"^^xsd:date ;
  schema:citation <https://www.arcetherapeutics.com/>, <https://www.arcetherapeutics.com/about_us/history>, <https://clinicaltrials.gov/study/NCT06680752> ;
  schema:addressCountry "TW" ;
  onco:cancers <https://onco.cc/cancers/aml/>, <https://onco.cc/cancers/mds/> ;
  onco:sections <https://onco.cc/fronts/cell-therapy/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/car-t/> ;
  onco:trials <https://onco.cc/trials/nct06680752/> .